Department of Integrative Medical Sciences, Northeastern Ohio Universities College of Medicine, 4209 State Rte. 44, Rootstown, OH 44272, USA.
Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):328-36. doi: 10.1161/ATVBAHA.110.217828. Epub 2010 Nov 11.
Loss-of-function mutations in human hepatocyte nuclear factor 4α (HNF4α) are associated with maturity-onset diabetes of the young and lipid disorders. However, the mechanisms underlying the lipid disorders are poorly understood. In this study, we determined the effect of acute loss or augmentation of hepatic HNF4α function on lipid homeostasis.
We generated an adenovirus expressing LacZ (Ad-shLacZ) or short hairpin RNA of Hnf4α (Ad-shHnf4α). Tail vain injection of C57BL/6J mice with Ad-shHnf4α reduced hepatic Hnf4α expression and resulted in striking phenotypes, including the development of fatty liver and a >80% decrease in plasma levels of triglycerides, total cholesterol, and high-density lipoprotein cholesterol. These latter changes were associated with reduced hepatic lipogenesis and impaired very-low-density lipoprotein secretion. Deficiency in hepatic Hnf4α did not affect intestinal cholesterol absorption despite decreased expression of genes involved in bile acid synthesis. Consistent with the loss-of-function data, overexpression of Hnf4α induced numerous genes involved in lipid metabolism in isolated primary hepatocytes. Interestingly, many of these HNF4α-regulated genes were not induced in wild-type mice that overexpressed hepatic Hnf4α. Because of selective gene regulation, mice overexpressing hepatic Hnf4α had unchanged plasma triglyceride levels and decreased plasma cholesterol levels.
Loss of hepatic HNF4α results in severe lipid disorder as a result of dysregulation of multiple genes involved in lipid metabolism. In contrast, augmentation of hepatic HNF4α activity lowers plasma cholesterol levels but has no effect on plasma triglyceride levels because of selective gene regulation. Our data indicate that hepatic HNF4α is essential for controlling the basal expression of numerous genes involved in lipid metabolism and is indispensable for maintaining normal lipid homeostasis.
人类肝细胞核因子 4α(HNF4α)的功能丧失性突变与青年发病的成年型糖尿病和脂代谢紊乱相关。然而,脂代谢紊乱的机制仍不清楚。本研究旨在确定肝脏 HNF4α 功能的急性丧失或增强对脂稳态的影响。
我们构建了表达 LacZ(Ad-shLacZ)或 Hnf4α 短发夹 RNA(Ad-shHnf4α)的腺病毒。尾静脉注射 Ad-shHnf4α 可降低 C57BL/6J 小鼠肝脏 Hnf4α 的表达,并导致明显的表型,包括脂肪肝的发生以及血浆甘油三酯、总胆固醇和高密度脂蛋白胆固醇水平降低超过 80%。这些变化与肝内脂质生成减少和极低密度脂蛋白分泌受损有关。尽管参与胆汁酸合成的基因表达下调,但肝脏 Hnf4α 缺乏并不影响肠道胆固醇吸收。与功能丧失数据一致,Hnf4α 的过表达在分离的原代肝细胞中诱导了许多与脂质代谢相关的基因。有趣的是,许多这些 HNF4α 调节的基因在过表达肝 Hnf4α 的野生型小鼠中没有被诱导。由于基因的选择性调控,过表达肝 Hnf4α 的小鼠的血浆甘油三酯水平没有变化,而血浆胆固醇水平降低。
肝脏 HNF4α 的缺失导致参与脂质代谢的多个基因失调,从而导致严重的脂代谢紊乱。相比之下,肝脏 HNF4α 活性的增强降低了血浆胆固醇水平,但由于基因的选择性调控,对血浆甘油三酯水平没有影响。我们的数据表明,肝脏 HNF4α 是控制许多参与脂质代谢的基因基础表达所必需的,并且对维持正常脂质稳态是不可或缺的。